Showing results (591-600 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|December 17, 2009
Platelet count less than SHARP: what does a case series reveal?M Wasif SaifExpert Opinion on Drug Safety|December 17, 2009
Inherent and iatrogenic immune defects in hairy cell leukemia: revisitedConstantin A Dasanu, T E Ichim, Doru T AlexandrescuExpert Opinion on Drug Safety|December 17, 2009
Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literatureAndreas Holstein, Helger Stege, Peter KovacsExpert Opinion on Drug Safety|December 9, 2009
Ezetimibe/simvastatinFabrizio Montecucco, Alessandra Quercioli, François MachExpert Opinion on Drug Safety|October 1, 2021
Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson's diseaseKanako Kurihara, Takayasu Mishima, Shinsuke Fujioka, et al.Expert Opinion on Drug Safety|April 25, 2022
Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directionsStuart H Isaacson, Leslie CitromeExpert Opinion on Drug Safety|October 13, 2021
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinomaAlessia Villani, Sonia Sofia Ocampo-Garza, Luca Potestio, et al.Expert Opinion on Drug Safety|September 27, 2021
Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular riskJanne Kaergaard Mortensen, Grethe AndersenExpert Opinion on Drug Safety|April 22, 2022
Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertensionSung-A Chang, Sang Hyun Lee, Jung Hyun Choi, et al.Expert Opinion on Drug Safety|April 25, 2023
Safety considerations in the management of hepatitis C and HIV co-infectionVicente Soriano, Víctor Moreno-Torres, Ana Treviño, et al.Pageof 282